Unable to display this Web Part. To troubleshoot the problem, open this Web page in a Microsoft SharePoint Foundation-compatible HTML editor such as Microsoft SharePoint Designer. If the problem persists, contact your Web server administrator.

Correlation ID:c31b9e2b-d9ab-4e36-9e23-5f676a790b4f

Introduction Untangling the Roles of Antidepressants and Mood Stabilizers in the Treatment of Alzheimer's Disease

View This PDF

NB: This article is only available as a PDF.

Two articles and a commentary in this issue underscore the need to clarify the roles of antidepressants and mood stabilizers in the treatment of Alzheimer’s disease (AD). Siddique and colleagues investigate the effects of the selective serotonin reuptake inhibitor (SSRI) citalopram on the treatment of irritability and apathy in AD. Hampel and colleagues use a biomarker strategy to investigate the potential of lithium to modify tau phosphorylation, a cardinal feature of AD pathology.

J Clin Psychiatry 2009;70(6):913-914